Using Real-World Evidence to Improve Patient Outcomes
We help Life Sciences organizations reduce the burden of disease by providing the industry’s most complete technology solutions. The breadth, depth, and timeliness of our data make it easier for you to uncover opportunities to improve disease management and care outcomes, to identify collaborators within healthcare communities, to test innovations, and to scale adoption of proven therapeutics.
Optimize the Product Life Cycle
Create complex cohorts in less than ten minutes, fast-track patient recruitment, and select clinical trial sites based on data, not habit or guesswork.
Optimize your Medical Affairs strategies and workflows by identifying and prioritizing HCPs to include clinical volumes, receptivity to trial collaboration, and bibliometric, scientific, and social media data. Build comprehensive solutions for medical inquiry, patient portals, publication planning, and more.
Gain a competitive advantage with real-time, real-world evidence that drives marketing and sales strategies and lets you continuously optimize field engagement.
Generate clinical evidence with patient-outcome and comparative-economic studies that drive policy and reimbursement decisions, and ultimately improve patient access to change lives.
What Life Sciences Customers Say
Komodo’s technology and real-time data help thread the needle on everything from clinical sites and physician engagement to patients with relevant diagnoses.
VP of Global Medical and Scientific Affairs, Karyopharm Therapeutics
Our MSLs have come to depend on the intimate territory knowledge Komodo offers. Now they have the tools to be the CEO of their own territory.
Komodo’s clinical alerts have revolutionized our way of doing business. We have relevant, accurate information at the precise moment we need it for our conversations with providers.
In our experience with real-world-evidence research, this technology has played a pivotal role in offering a timely, comprehensive, and accurate view of patient journeys to drive evidence around disease burden and health outcomes.
Global Head of Innovation, Data, and Analytics, Kantar Health